Home > Products > Novel inhibitors
Cat. No. Product name CAS No.
DCC1566 Cremastranone

Natural antiangiogenic homoisoflavanone, inhibiting the proliferation, migration and tube formation ability of human retinal microvascular endothelial cells

107585-69-3
DCC1567 Cribrostatin 6

Antineoplastic and Antibacterial; Inducer of death in cancer cells through a reactive oxygen species (ROS)-mediated mechanism; Dark blue cancer cell growth inhibitor

518056-45-6
DCC1568 Crl-40940

Selective dopaminergic reuptake inhibitor

90280-13-0
DCC1569 Crom-1

Novel potent, selective, and reversible inhibitor of human monoamine oxidase B (hMAO-B)

DCC1570 Crom-2

Novel potent, selective, and reversible inhibitor of human monoamine oxidase B (hMAO-B)

DCC1571 Crs400359

Novel potent and mycobacteria-specific antimycobacterial agent, targeting MmpL3, improving the antimycobacterial activity and being also potent against Mtb

DCC1572 Crs400393

Novel potent and mycobacteria-specific antimycobacterial agent, targeting MmpL3, a mycobacterial mycolic acid transporterr, demonstrating MIC = 0.03, 2, and ≤ 0.12 μg/mL against Mabs, Mycobacterium avium complex (MAC), and Mtb respectively

2253175-64-1
DCC1573 Crt0083914

Potent and selective inhibitor of AKR1C3

932495-16-4
DCC1574 Crt0093964

Potent and selective inhibitor of AKR1C3

700856-05-9
DCC1575 Crth2 Antagonist K117

Potent and selective CRTH2 antagonist

308289-84-1
DCC1576 Crx-526

TLR4 antagonist, protecting against advanced diabetic nephropathy

245515-64-4
DCC1577 Crx-527

Novel potent powerful lipid A analogue as a conjugation-ready TLR4 ligand

DCC1578 Cryosim-1

Novel TRPM8 agonist

1487170-15-9
DCC1579 Cryosim-3

Novel water-soluble, potent, and selective TRPM8 receptor agonist

1507344-37-7
DCC1580 Cryptopleurine

Inhibitor of gene products associated with cell survival, proliferation, invasion, and angiogenesis, targeting NF-κB pathway, showing antiproliferative activity and unique mode of action

482-22-4
DCC1581 Cryptozepine-2

Novel photoisomerizable potent and selective M1 ligand, mimicing the tricyclic chemical structure and display reversibly controlled activity, showing stronger inhibition upon illumination both in vitro and in cardiac atria ex vivo

DCC1582 Csl-32

Novel modulator of PI3K and NF-κB activities, blocking migration and production of inflammatory mediators

DCC1583 C-src-in-12

Novel substrate-competive c-Src inhibitor

DCC1584 Csv0c018875 Hydrochloride

Novel G9a (EHMT2) inhibitor, binding tightly inside the active site cavity of G9a, inhibiting the activity of G9a in both enzyme and cell based assays with much lesser toxicity than BIX-0129

474084-56-5
DCC1585 Ct-2584

Dual inhibitor of angiogenesis and lysophosphatidic acid acyltransferase

166981-13-1
DCC1586 Ct-711

Novel potent dual inhibitor of ALK and c-Met

DCC1587 Ct-mz1

Novel cell permeable degrader of BRD4

Page 1293 / Total 1557 FirstPrevNextLastGoto